Does SUMATRIPTAN Cause Application site vesicles? 262 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 262 reports of Application site vesicles have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 1.5% of all adverse event reports for SUMATRIPTAN.
262
Reports of Application site vesicles with SUMATRIPTAN
1.5%
of all SUMATRIPTAN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Application site vesicles From SUMATRIPTAN?
Of the 262 reports, 1 (0.4%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 262 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
MECHLORETHAMINE (73)
Which SUMATRIPTAN Alternatives Have Lower Application site vesicles Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT